Literature DB >> 26303153

Comparative effectiveness of cardiac implantable electrical devices.

Daniel B Kramer1, Laura A Hatfield2, Sharon-Lise T Normand3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26303153      PMCID： PMC4699558          DOI： 10.1136/heartjnl-2015-308295

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  9 in total

Review 1.  Implantable Cardioverter-Defibrillator Use in Older Adults: Proceedings of a Hartford Change AGEnts Symposium.

Authors:  Daniel B Kramer; Daniel D Matlock; Alfred E Buxton; Nathan E Goldstein; Carol Goodwin; Ariel R Green; James N Kirkpatrick; Christopher Knoepke; Rachel Lampert; Paul S Mueller; Matthew R Reynolds; John A Spertus; Lynne W Stevenson; Susan L Mitchell
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-06-02

2.  HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.

Authors:  Fred M Kusumoto; Hugh Calkins; John Boehmer; Alfred E Buxton; Mina K Chung; Michael R Gold; Stefan H Hohnloser; Julia Indik; Richard Lee; Mandeep R Mehra; Venu Menon; Richard L Page; Win-Kuang Shen; David J Slotwiner; Lynne Warner Stevenson; Paul D Varosy; Lisa Welikovitch
Journal:  Circulation       Date:  2014-05-09       Impact factor: 29.690

3.  Mortality reduction in relation to implantable cardioverter defibrillator programming in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT).

Authors:  Anne-Christine Ruwald; Claudio Schuger; Arthur J Moss; Valentina Kutyifa; Brian Olshansky; Henry Greenberg; David S Cannom; N A Mark Estes; Martin H Ruwald; David T Huang; Helmut Klein; Scott McNitt; Christopher A Beck; Robert Goldstein; Mary W Brown; Josef Kautzner; Morio Shoda; David Wilber; Wojciech Zareba; James P Daubert
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-08-18

4.  Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.

Authors:  Robbert Zusterzeel; Erica S Spatz; Jeptha P Curtis; William E Sanders; Kimberly A Selzman; Ileana L Piña; Haikun Bao; Angelo Ponirakis; Paul D Varosy; Frederick A Masoudi; Daniel A Caños; David G Strauss
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-02-24

5.  Meta-analysis of rate ratios with differential follow-up by treatment arm: inferring comparative effectiveness of medical devices.

Authors:  Lauren M Kunz; Sharon-Lise T Normand; Art Sedrakyan
Journal:  Stat Med       Date:  2015-05-24       Impact factor: 2.373

6.  Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials.

Authors:  Patrick H Pun; Sana M Al-Khatib; Joo Yoon Han; Rex Edwards; Gust H Bardy; J Thomas Bigger; Alfred E Buxton; Arthur J Moss; Kerry L Lee; Richard Steinman; Paul Dorian; Al Hallstrom; Riccardo Cappato; Alan H Kadish; Peter J Kudenchuk; Daniel B Mark; Paul L Hess; Lurdes Y T Inoue; Gillian D Sanders
Journal:  Am J Kidney Dis       Date:  2014-02-08       Impact factor: 8.860

Review 7.  Predictors of mortality in patients with an implantable cardiac defibrillator: a systematic review and meta-analysis.

Authors:  Ana C Alba; Juarez Braga; Mena Gewarges; Stephen D Walter; Gordon H Guyatt; Heather J Ross
Journal:  Can J Cardiol       Date:  2013-10-01       Impact factor: 5.223

Review 8.  Making decisions about implantable cardioverter-defibrillators from implantation to end of life: an integrative review of patients' perspectives.

Authors:  Krystina B Lewis; Dawn Stacey; Dan D Matlock
Journal:  Patient       Date:  2014       Impact factor: 3.883

Review 9.  Individual patient data network meta-analysis of mortality effects of implantable cardiac devices.

Authors:  B Woods; N Hawkins; S Mealing; A Sutton; W T Abraham; J F Beshai; H Klein; M Sculpher; C J Plummer; M R Cowie
Journal:  Heart       Date:  2015-08-12       Impact factor: 5.994
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.